HAPPENING: PFIZER RESEARCHER DUMPS DOCS SHOWING FALSIFIED DATA DURING COVID VAX TRIALS
>A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.
>In a list of “action items” circulated among Ventavia leaders in early August 2020, shortly after the trial began and before Jackson’s hiring, a Ventavia executive identified three site staff members with whom to “Go over e-diary issue/falsifying data, etc.” One of them was “verbally counseled for changing data and not noting late entry,” a note indicates.
>The next morning, 25 September 2020, Jackson called the FDA to warn about unsound practices in Pfizer’s clinical trial at Ventavia. She then reported her concerns in an email to the agency. In the afternoon Ventavia fired Jackson—deemed “not a good fit,” according to her separation letter.
>Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.
https://www.bmj.com/content/375/bmj.n2635
https://web.archive.org/web/20211102150906/https://www.bmj.com/content/375/bmj.n2635
https://archive.md/BfcjQ